Databases: Scientists' and Organizations' Links to Industry
Return to CSPI U.S.
Non-Profit Organizations Receiving Corporate Funding 
Index of Non-Profit Organizations Receiving Corporate Funding

The National Organization for Rare Disorders (NORD), a 501(c)3 organization, is a unique federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service. (; accessed 4/29/08)

Members of Corporate Council (; accessed 5/8/08):

Accredo Health, Inc.

Acorda Therapeutics

Actelion Pharmaceuticals US, Inc.

Alexion Pharmaceuticals, Inc.


Altus Pharmaceuticals

Amicus Therapeutics, Inc.

Antigenics, Inc.

Applied Genetic Technologies Corp.

Aspreva Pharmaceuticals

Astra Zeneca Pharmaceuticals LP

Aton Pharma Inc

Avigen, Inc.

Bausch & Lomb Pharmaceuticals

Bausch & Lomb Surgical Division Retina Marketing

BioMarin Pharmaceuticals, Inc.

Brushcreek LLC/Errant Gene Therapeutics

Celgene Corporation

Duchesnay, Inc.

Endo Pharmaceuticals

Engage Health, Inc.

FFF Enterprises

FoldRX Pharmaceuticals, Inc.

Genzyme Therapeutics

Hemophelia Health Services


Hyperion Therapeutics

IDIS Pharmaceuticals

Impax Laboratories, Inc.


Insmed Incorporated

Jazz Pharmaceuticals

Johnson & Johnson

Mark Krueger & Associates, Inc.

Medtronic, Inc.

Millennium Pharmaceuticals

Neurochem, Inc.

NexGenix Pharmaceuticals

Prestwick Pharmaceuticals

PTC Therapeutics Inc

Purdue Pharma

Questcor Pharmaceuticals, Inc.

Rare Disease Therapeutics, Inc.

Sanofi-Aventis, Inc.

Shire Pharmaceuticals

Sigma-Tau Pharmaceuticals

Ucyclyd Pharma (Medicis)

United Therapeutics Corporation

ZioPharm Oncology, Inc.

[Integrity in Science] [CSPI U.S.] Back to Top